FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine and pharmaceutics and represents a recombinant tuberculosis vaccine comprising an effective amount of recombinant protein ESAT6-CFP10-Ag85a-Rv2660c, which is fused mycobacterial proteins ESAT-6, CFP10, Ag85a, Rv2660c with histidine tag with length of 8 residues, and an adjuvant represented by a CPG oligonucleotide and a muramyl dipeptide, wherein the recombinant protein and the adjuvant are immobilized on carrier particles from a lactic and glycolic acid copolymer PLGA.
EFFECT: increased immunogenic action of recombinant protein-antigen ESAT6-CFP10-Ag85a-Rv2660c in combination with adjuvant presented by CpG-ODN of class A and N-acetylmuramyl-L-alanyl-D-isoglutamine.
5 cl, 13 dwg, 10 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT TUBERCULOUS VACCINE AND ADJUVANT FOR IT | 2017 |
|
RU2665817C1 |
| RECOMBINANT PLASMID pESAT6-CFP10-DBD, RECOMBINANT STRAIN Escherichia coli M15 [pREP4, pESAT6-CFP10-DBD], METHOD FOR PREPARING, IMMOBILISING, CONCENTRATING AND PURIFYING RECOMBINANT PROTEIN ESAT6-CFP10-DBD ON DEXTRAN, RECOMBINANT PROTEIN ESAT6-CFP10-DBD AND IMMUNOGENIC COMPOSITION CONTAINING PROTEIN ESAT6-CFP10-DBD | 2013 |
|
RU2539026C1 |
| METHOD FOR OBTAINING IMMUNOGENIC COMPOSITION BASED ON CFP10-DBD HYBRID PROTEIN AND DEXTRANE; pCFP10-DBD RECOMBINANT PLASMIDE; Escherichia coli [pREP4, pCFP10-DBD] STRAIN; CFP10-DBD CHIMERIC PROTEIN AND THEIR APPLICATION | 2013 |
|
RU2546875C1 |
| METHOD FOR EVALUATING ACTIVITY OF TUBERCULOSIS INFECTION IN CHILDREN AND ADOLESCENTS | 2015 |
|
RU2586279C1 |
| RECOMBINANT STRAIN MYCOBACTERIUM BOVIS rBCG-1 BASED ON VACCINE STRAIN MYCOBACTERIUM BOVIS BCG STRAIN RUSSIA 368 | 2022 |
|
RU2807732C1 |
| RECOMBINANT PLASMID, Escherichia coli STRAIN, CHIMERIC PROTEIN AND THEIR APPLICATION | 2010 |
|
RU2422525C1 |
| METHOD OF PRODUCTION OF IMMUNOGENIC COMPOSITION BASED ON FUSION PROTEIN pESAT6-DBD AND DEXTRAN, RECOMBINANT PLASMID pESAT6-DBD, STRAIN OF Escherichia coli, CHIMERIC PROTEIN ESAT6-DBD AND THEIR APPLICATION | 2013 |
|
RU2520737C1 |
| METHOD FOR OBTAINING IMMUNOGENIC COMPOSITION BASED ON Ag85A-DBD HYBRID PROTEIN AND DEXTRANE; pAg85A-DBD RECOMBINANT PLASMIDE; Escherichia coli [pREP4, pAg85A-DBD] STRAIN; Ag85A-DBD CHIMERIC PROTEIN | 2013 |
|
RU2520078C1 |
| VACCINE COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF TUBERCULOSIS INFECTION AND GENETIC CONSTRUCTIONS FOR PREPARING ACTING COMPONENTS OF THIS COMPOSITION | 2003 |
|
RU2262351C1 |
| HYBRID PROTEIN CFP10-ESAT6, INDUCING REACTION OF HYPERSENSITIVITY OF DELAYED TYPE WITH RESPECT TO M.Tuberculosis, CODING IT CHIMERIC NUCLEIC ACID AND RECOMBINANT PLASMID EXPRESSION VECTOR, CONTAINING IT, METHOD OF OBTAINING HYBRID PROTEIN AND BASED ON IT DOSED MEDICINAL FORM FOR INTRACUTANEOUS INJECTION | 2008 |
|
RU2360926C9 |
